Diamminedinitritoplatinum(II) CAS: 14286-02-3
Catalog Number | XD94400 |
Product Name | Diamminedinitritoplatinum(II) |
CAS | 14286-02-3 |
Molecular Formula | H4N4O4Pt |
Molecular Weight | 319.14 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
Diamminedinitritoplatinum(II), also known as cisplatin, is a platinum-based chemotherapy drug that has revolutionized the treatment of various types of cancers. It is an important and widely used medication in the field of oncology, with applications in the treatment of ovarian, testicular, bladder, lung, and many other forms of cancer.The main mechanism of action of cisplatin is its ability to induce DNA cross-linking within cancer cells. It forms covalent bonds with DNA, causing structural damage and preventing the replication and transcription processes necessary for cancer cell growth. This ultimately leads to cell cycle arrest and programmed cell death, known as apoptosis.Cisplatin is administered intravenously and is typically used in combination with other chemotherapy agents to enhance its effectiveness. It has demonstrated remarkable success in treating certain cancers, significantly improving patient survival rates and remission durations. In particular, cisplatin is highly effective against testicular and ovarian cancers, where it is often used as a first-line treatment. It has also proven effective in the management of advanced bladder cancer, lung cancer, and several other types of solid tumors.Despite its efficacy, cisplatin is not without side effects. Common adverse reactions include nausea, vomiting, kidney damage, hearing loss, and peripheral neuropathy. Ongoing research is focused on minimizing these side effects through the development of new administration strategies, such as nanoparticle-based delivery systems and targeted therapies.In addition to its direct applications in cancer treatment, cisplatin has also found use in laboratory research and diagnostic tests. In research, cisplatin is employed as a tool to study DNA damage response mechanisms and investigate the underlying molecular pathways involved in cancer progression. It is also used in diagnostic assays to assess DNA adduct levels, which can help predict the potential effectiveness of cisplatin treatment.In conclusion, diamminedinitritoplatinum(II), known as cisplatin, is a pivotal chemotherapeutic agent in the fight against various types of cancer. Its ability to induce DNA cross-linking and promote apoptosis within cancer cells has made it a cornerstone of modern oncology. Although it is associated with side effects, ongoing research aims to improve its therapeutic index and explore novel delivery mechanisms. With its widespread applications and continued advancements, cisplatin continues to make significant contributions to the field of cancer treatment.